Have a personal or library account? Click to login
Effect of AgNPs on the human reconstructed epidermis Cover

Effect of AgNPs on the human reconstructed epidermis

Open Access
|Oct 2019

Abstract

Nanoparticles are utilized in a wide range of industries. The most studied silver nanoparticles (AgNPs) are used in medicine and also in several wound dressings due to their antimicrobial properties. The inflammatory response or potential morphological changes of skin cells after their application are not well known yet. In our study we used the model of human reconstructed epidermis (RHE), prepared in our laboratory, to evaluate whether the AgNPs penetrate through RHE, induce some morphological changes of keratinocytes or influence the production of pro-inflammatory cytokines (IL-6 and IL-8). After the application of three different concentrations (25 ppm, 2.5 ppm, 0.25 ppm) of AgNPs to of RHE for 24 hours we verified that AgNPs did not affect the production of pro-inflammatory cytokines (IL-6 and IL-8) and neither did they influence the expression of keratin K14 and loricrin. The morphology of the cells was likewise unchanged. Based on these results we conclude that AgNPs do not have any negative effect on the morphological changes and do not increase the production of pro-inflammatory cytokines.

DOI: https://doi.org/10.2478/intox-2018-0028 | Journal eISSN: 1337-9569 | Journal ISSN: 1337-6853
Language: English
Page range: 289 - 293
Submitted on: Nov 21, 2017
Accepted on: Feb 23, 2018
Published on: Oct 18, 2019
Published by: Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2019 Jana Franková, Jana Juráňová, Vojtěch Kamarád, Bohumil Zálešák, Jitka Ulrichová, published by Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.